Efficacy of barrier creams.
Grunewald
A M
AM
Dermatological Clinic of Karlsruhe Municiipal Hospital, Mannheim, Germany.
Gloor
M
M
Gehring
W
W
Kleesz
P
P
D000328:Adult; D001557:Benzenesulfonates / Q000494:pharmacology / Q000627:therapeutic use*; D001834:Body Water / Q000378:metabolism; D002368:Castor Oil / Q000494:pharmacology / Q000627:therapeutic use*; D017453:Dermatitis, Irritant / Q000517:prevention & control*; D004338:Drug Combinations; D004817:Epidermis / Q000187:drug effects* / Q000378:metabolism; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D017078:Laser-Doppler Flowmetry; D008055:Lipids / Q000032:analysis; D008297:Male; D009824:Ointments / Q000627:therapeutic use*; D010539:Permeability / Q000187:drug effects; D012039:Regional Blood Flow; D012629:Sebum / Q000737:chemistry; D012833:Siloxanes / Q000494:pharmacology / Q000627:therapeutic use*; D012867:Skin / Q000098:blood supply; D012967:Sodium Dodecyl Sulfate / Q000009:adverse effects* / Q000493:pharmacokinetics; D013228:Stearates / Q000494:pharmacology / Q000627:therapeutic use*; D014885:Waxes / Q000494:pharmacology / Q000627:therapeutic use*
D001557:Benzenesulfonates; D004338:Drug Combinations; D008055:Lipids; D009824:Ointments; D012833:Siloxanes; D013228:Stearates; D014885:Waxes; C094967:marly skin; C094966:saniwip; C094965:tactosan; D012967:Sodium Dodecyl Sulfate; D002368:Castor Oil